Dariush Etemadmoghadam
Researcher Next ID · RN-025675
Researcher · Medicine
Melbourne, Iceland
- Works count
- 216
- Citation count
- 27,729
- H-index
- 51
- i10-index
- 71
Research interests
Publications
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
Nature Genetics · 2020 · https://doi.org/10.1038/s41588-019-0576-7
Genomic footprints of activated telomere maintenance mechanisms in cancer
Nature Communications · 2020 · https://doi.org/10.1038/s41467-019-13824-9
Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition
Nature Genetics · 2020 · https://doi.org/10.1038/s41588-019-0562-0
Whole–genome characterization of chemoresistant ovarian cancer
Nature · 2015 · https://doi.org/10.1038/nature14410
Synthetic lethality between CCNE1 amplification and loss of BRCA1
Proceedings of the National Academy of Sciences · 2013 · https://doi.org/10.1073/pnas.1314302110
Cyclin E1 Deregulation Occurs Early in Secretory Cell Transformation to Promote Formation of Fallopian Tube–Derived High-Grade Serous Ovarian Cancers
Cancer Research · 2013 · https://doi.org/10.1158/0008-5472.can-13-2247
Prognostically relevant gene signatures of high-grade serous ovarian carcinoma
Journal of Clinical Investigation · 2012 · 10.1172/jci65833
Rethinking ovarian cancer: recommendations for improving outcomes
Nature reviews. Cancer · 2011 · https://doi.org/10.1038/nrc3144
Deregulation of MYCN, LIN28B and LET7 in a Molecular Subtype of Aggressive High-Grade Serous Ovarian Cancers
PLoS ONE · 2011 · https://doi.org/10.1371/journal.pone.0018064
Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
The Journal of Pathology · 2010 · https://doi.org/10.1002/path.2696
Integrated Genome-Wide DNA Copy Number and Expression Analysis Identifies Distinct Mechanisms of Primary Chemoresistance in Ovarian Carcinomas
Clinical Cancer Research · 2009 · https://doi.org/10.1158/1078-0432.ccr-08-1564
Evidence that Inositol Polyphosphate 4-Phosphatase Type II Is a Tumor Suppressor that Inhibits PI3K Signaling
Cancer Cell · 2009 · https://doi.org/10.1016/j.ccr.2009.06.006
Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
Clinical Cancer Research · 2008 · https://doi.org/10.1158/1078-0432.ccr-08-0196
Current projects
No projects listed.